PNC Financial Services Group
SRNE

PNC Financial Services Group’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

PNC Financial Services Group’s Portfolio SRNE Stock Details SRNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-80
Closed -$71 – 4892
2022
Q4 		$71 Sell
80
-1,980
-96% -$2.63K ﹤0.01% 4713
2022
Q3 		$3K Sell
2,060
-16,000
-89% -$36.3K ﹤0.01% 4133
2022
Q2 		$36K Buy
18,060
+15,000
+490% +$25.9K ﹤0.01% 3194
2022
Q1 		$7K Hold
3,060
– – ﹤0.01% 3929
2021
Q4 		$14K Sell
3,060
-2,282
-43% -$14.2K ﹤0.01% 3693
2021
Q3 		$41K Hold
5,342
– – ﹤0.01% 3189
2021
Q2 		$51K Buy
5,342
+1,982
+59% +$15.8K ﹤0.01% 3063
2021
Q1 		$28K Sell
3,360
-1,564
-32% -$16.5K ﹤0.01% 3278
2020
Q4 		$34K Sell
4,924
-1,776
-27% -$14.3K ﹤0.01% 3129
2020
Q3 		$75K Sell
6,700
-24,201
-78% -$221K ﹤0.01% 2488
2020
Q2 		$194K Buy
+30,901
New +$118K ﹤0.01% 1951
2018
Q4 		– Sell
-4,500
Closed -$20K – 4231
2018
Q3 		$20K Hold
4,500
– – ﹤0.01% 3456
2018
Q2 		$32K Hold
4,500
– – ﹤0.01% 3266
2018
Q1 		$23K Buy
+4,500
New +$32K ﹤0.01% 3378
2017
Q2 		– Sell
-2,400
Closed -$9K – 4251
2017
Q1 		$9K Hold
2,400
– – ﹤0.01% 3585
2016
Q4 		$12K Hold
2,400
– – ﹤0.01% 3431
2016
Q3 		$19K Hold
2,400
– – ﹤0.01% 3256
2016
Q2 		$13K Hold
2,400
– – ﹤0.01% 3440
2016
Q1 		$13K Hold
2,400
– – ﹤0.01% 3467
2015
Q4 		$21K Sell
2,400
-74,261
-97% -$626K ﹤0.01% 3282
2015
Q3 		$643K Buy
+76,661
New +$1.22M ﹤0.01% 1422

Other funds holding SRNE

PP
Paloma Partners Greenwich, Connecticut $1.36B AUM 249.29% 1-Year Est. Return
Oaktree Capital Management
Oaktree Capital Management Los Angeles, California $7.21B AUM 45.97% 1-Year Est. Return
OFA
Oaktree Fund Advisors Los Angles, California $57.8M AUM 67.22% 1-Year Est. Return
CGA
Crescent Grove Advisors Lake Forest, Illinois $1.2B AUM 23.08% 1-Year Est. Return
LCM
Lattice Capital Management Kirkland, Washington $49.5M AUM 28.58% 1-Year Est. Return
STB
S&T Bank Indiana, Pennsylvania $333M AUM 106.39% 1-Year Est. Return
GA
GoalVest Advisory New York $578M AUM 17.41% 1-Year Est. Return
HFRG
Houlihan Financial Resource Group Ashburn, Virginia $281M AUM 17.68% 1-Year Est. Return
Valeo Financial Advisors
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 19.15% 1-Year Est. Return
GBWM
Granite Bay Wealth Management Portsmouth, New Hampshire $1.09B AUM 22.93% 1-Year Est. Return

PNC Financial Services Group's SRNE Position: Q1 2023 in Review

PNC Financial Services Group sold out of Sorrento Therapeutics, Inc. (SRNE) in Q1 2023, closing a stake of 80 shares — an estimated $71 sold.

PNC Financial Services Group first reported a position in SRNE in Q3 2015 and held it in 21 quarters. The position peaked at $643K in Q3 2015. 34 funds tracked by Wall St. Rank hold SRNE as of Q1 2023.

  • PNC Financial Services Group reported no remaining Sorrento Therapeutics, Inc. position as of Q1 2023 after selling out during the quarter.
  • PNC Financial Services Group sold 80 Sorrento Therapeutics, Inc. shares in Q1 2023, an estimated $71.
  • PNC Financial Services Group first reported a position in Sorrento Therapeutics, Inc. in Q3 2015 and held it in 21 quarters.
  • PNC Financial Services Group's Sorrento Therapeutics, Inc. position peaked at $643K in Q3 2015.
  • 34 funds tracked by Wall St. Rank held Sorrento Therapeutics, Inc. as of Q1 2023.

Based on PNC Financial Services Group's 13F filing for Q1 2023, filed 15 May 2023.